Wolverine Asset Management
TLSIW icon

Wolverine Asset Management’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Wolverine Asset Management’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,990
Closed -$51.4K – 1923
2025
Q4 		$51.4K Buy
+30,990
New +$39.5K ﹤0.01% 1276
2025
Q2 		– Sell
-8,735
Closed -$10.6K – 1788
2025
Q1 		$10.6K Sell
8,735
-5,165
-37% -$6.67K ﹤0.01% 1306
2024
Q4 		$15.3K Sell
13,900
-851
-6% -$1.01K ﹤0.01% 1318
2024
Q3 		$14.9K Buy
+14,751
New +$19.8K ﹤0.01% 1295
2024
Q2 		– Sell
-117,290
Closed -$117K – 1781
2024
Q1 		$117K Buy
117,290
+13,540
+13% +$13.5K ﹤0.01% 1028
2023
Q4 		$123K Buy
+103,750
New +$45.8K ﹤0.01% 1104

Other funds holding TLSIW

Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Vestcor Inc
Vestcor Inc Fredericton, New Brunswick, Canada $4.05B AUM 34.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Aristeia Capital
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
Fort Baker Capital Management
Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return

Wolverine Asset Management's TLSIW Position: Q1 2026 in Review

Wolverine Asset Management sold out of TriSalus Life Sciences Warrant (TLSIW) in Q1 2026, closing a stake of 30,990 shares — an estimated $51.4K sold.

Wolverine Asset Management first reported a position in TLSIW in Q4 2023 and held it in 6 quarters. The position peaked at $123K in Q4 2023. 7 funds tracked by Wall St. Rank hold TLSIW as of Q1 2026.

  • Wolverine Asset Management reported no remaining TriSalus Life Sciences Warrant position as of Q1 2026 after selling out during the quarter.
  • Wolverine Asset Management sold 30,990 TriSalus Life Sciences Warrant shares in Q1 2026, an estimated $51.4K.
  • Wolverine Asset Management first reported a position in TriSalus Life Sciences Warrant in Q4 2023 and held it in 6 quarters.
  • Wolverine Asset Management's TriSalus Life Sciences Warrant position peaked at $123K in Q4 2023.
  • 7 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.